What is PTNTD's earnings per share (EPS)?

PTNTD (PTNTD) reported diluted earnings per share of $-32.15 for fiscal year 2025. This represents a 68.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PTNTD Financials

PTNTD

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE June

This page shows PTNTD (PTNTD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PTNTD FY2025 2026-04-22

External financing rather than product revenue is still carrying a research-heavy operating model as liquidity thins.

By FY2024, revenue was only $4.5M while operating cash burn was about $31.5M, showing customer-funded scale remains far smaller than the operating base. With cash down to $9.5M from $29.9M two years earlier, the company is effectively funding a research-heavy model through capital raises rather than internally generated cash.

Capex was only $43K in FY2024, so free cash flow tracked operating cash flow closely. That makes the cash burn an operating issue, not a capital-intensity story driven by heavy equipment or facility spending.

The liquidity cushion has compressed: current ratio fell from 2.1x in FY2022 to about 1.0x in FY2024, and liabilities edged above assets. That helps explain why FY2024 still needed $20.5M of financing inflow despite revenue of just $4.5M.

Financial Health Signals

Financial Profile 13/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of PTNTD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

PTNTD's revenue declined 100% year-over-year, from $4.5M to $0. This contraction results in a growth score of 0/100.

Leverage

PTNTD carries a low D/E ratio of -1.68, meaning only $-1.68 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 77/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

PTNTD's current ratio of 0.36 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

YoY-100.0%

PTNTD generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-32.15

YoY+68.2%

PTNTD earned $-32.15 per diluted share (EPS) in fiscal year 2025. This represents an increase of 68.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$2.6M

YoY-73.1%

5Y CAGR-50.1%

10Y CAGR-21.1%

PTNTD held $2.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

929,597

YoY+159.3%

PTNTD had 929,597 shares outstanding in fiscal year 2025. This represents an increase of 159.3% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$14.9M

YoY-33.5%

5Y CAGR+1.3%

10Y CAGR-4.9%

PTNTD invested $14.9M in research and development in fiscal year 2025. This represents a decrease of 33.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

YoY-100.0%

PTNTD invested $0 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.

PTNTD Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$0-100.0%	$4.5M-7.5%	$4.9M+230.5%	$1.5M	N/A	$118K
Cost of Revenue	N/A	$98K-76.7%	$418K+92.4%	$218K+47.1%	$148K	$0
Gross Profit	N/A	$4.4M-1.0%	$4.4M+254.6%	$1.3M+471.8%	-$336K-385.1%	$118K
R&D Expenses	$14.9M-33.5%	$22.4M-1.0%	$22.6M+6.1%	$21.3M+65.0%	$12.9M-7.4%	$14.0M
SG&A Expenses	$7.8M-36.4%	$12.3M-19.8%	$15.3M-7.4%	$16.5M-4.8%	$17.3M+77.5%	$9.8M
Operating Income	N/A	-$22.5M+30.7%	-$32.5M+11.3%	-$36.6M-9.6%	-$33.4M-41.4%	-$23.6M
Interest Expense	$15K-12.2%	$17K-14.5%	$20K-32.6%	$30K+26.6%	$23K+16.4%	$20K
Income Tax	N/A	$0+100.0%	-$4.7M	$0	N/A	$0
Net Income	N/A	-$29.7M-23.7%	-$24.0M+33.6%	-$36.2M-7.7%	-$33.6M-49.8%	-$22.4M
EPS (Diluted)	$-32.15+68.2%	$-101.16	N/A	N/A	N/A	$-0.10

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$116K-98.7%	$8.8M	N/A	$0	N/A	$0	N/A	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
R&D Expenses	$4.3M+71.0%	$2.5M	N/A	$3.8M+9.5%	$3.4M-40.3%	$5.7M	N/A	$7.2M
SG&A Expenses	$3.1M+88.2%	$1.7M	N/A	$1.5M-12.4%	$1.7M-16.8%	$2.0M	N/A	$2.0M
Operating Income	-$7.3M-257.2%	$4.7M	N/A	-$4.8M-84.3%	-$2.6M+66.4%	-$7.8M	N/A	-$9.2M
Interest Expense	$498-75.1%	$2K	N/A	$2K-52.8%	$4K-36.0%	$6K	N/A	$1K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Net Income	-$7.3M-255.3%	$4.7M	N/A	-$4.8M-97.0%	-$2.4M+68.8%	-$7.8M	N/A	-$8.4M
EPS (Diluted)	$-2.86-167.1%	$4.26	N/A	$-0.18+97.0%	$-5.92+70.0%	$-19.71	N/A	$-0.53

PTNTD Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.3M-69.6%	$10.7M-40.1%	$17.9M-50.3%	$36.1M-46.4%	$67.3M-20.9%	$85.1M
Current Assets	$2.9M-70.1%	$9.8M-40.1%	$16.3M-52.8%	$34.6M-47.5%	$65.9M-21.2%	$83.6M
Cash & Equivalents	$2.6M-73.1%	$9.5M-13.2%	$11.0M-63.3%	$29.9M-50.2%	$60.1M-27.5%	$82.9M
Inventory	N/A	$0-100.0%	$526K-44.3%	$944K-18.7%	$1.2M	$0
Accounts Receivable	$0	$0-100.0%	$2.9M+63.8%	$1.8M+12.6%	$1.6M	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$8.0M-25.9%	$10.9M-44.8%	$19.7M-0.7%	$19.8M+12.2%	$17.6M+261.5%	$4.9M
Current Liabilities	$8.0M-17.1%	$9.7M-36.2%	$15.1M-6.9%	$16.3M+54.7%	$10.5M+167.6%	$3.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$4.8M-4184.5%	-$111K+94.4%	-$2.0M-112.2%	$16.3M-67.2%	$49.7M-38.1%	$80.2M
Retained Earnings	-$459.1M-3.9%	-$441.8M-7.2%	-$412.0M-6.2%	-$388.0M-10.3%	-$351.8M-10.6%	-$318.2M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$17.9M+108.1%	$8.6M+163.7%	$3.3M-12.4%	$3.7M-13.5%	$4.3M+26.2%	$3.4M-68.2%	$10.7M-5.8%	$11.4M
Current Assets	$17.5M+108.7%	$8.4M+186.7%	$2.9M-9.7%	$3.2M-11.9%	$3.7M+40.5%	$2.6M-73.3%	$9.8M-4.9%	$10.3M
Cash & Equivalents	$14.5M+1037.1%	$1.3M-50.4%	$2.6M+1.7%	$2.5M-26.2%	$3.4M+43.3%	$2.4M-75.0%	$9.5M	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0
Accounts Receivable	$1.6M-76.2%	$6.9M	$0	N/A	N/A	N/A	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$6.5M-21.4%	$8.2M+2.2%	$8.0M-20.5%	$10.1M-5.4%	$10.7M-3.7%	$11.1M+2.3%	$10.9M+10.4%	$9.8M
Current Liabilities	$6.3M-22.9%	$8.2M+2.6%	$8.0M-20.3%	$10.0M+5.1%	$9.6M-3.1%	$9.9M+2.1%	$9.7M+13.2%	$8.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$11.5M+2792.5%	$396K+108.3%	-$4.8M+25.2%	-$6.4M-0.1%	-$6.4M+17.0%	-$7.7M-6793.1%	-$111K-107.1%	$1.6M
Retained Earnings	-$461.7M-1.6%	-$454.4M+1.0%	-$459.1M-0.5%	-$456.8M-1.1%	-$452.0M-0.5%	-$449.6M-1.8%	-$441.8M-1.9%	-$433.5M

PTNTD Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$31.5M-7.5%	-$29.3M+2.2%	-$29.9M-31855.8%	-$94K-100.2%	$41.3M
Capital Expenditures	$0-100.0%	$43K-90.2%	$434K+66.0%	$261K+4467.9%	$6K-90.9%	$63K
Free Cash Flow	N/A	-$31.5M-6.1%	-$29.7M+1.6%	-$30.2M-30278.5%	-$99K-100.2%	$41.3M
Investing Cash Flow	$3.1M-74.9%	$12.5M+463.3%	-$3.4M-1211.1%	-$261K-4467.9%	-$6K+90.9%	-$63K
Financing Cash Flow	$11.2M-45.4%	$20.5M+91.2%	$10.7M+58449.9%	$18K+100.1%	-$22.6M-1078.5%	-$1.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$4.8M-196.8%	-$1.6M+60.4%	-$4.1M+23.6%	-$5.4M-10.5%	-$4.8M+30.9%	-$7.0M-8.4%	-$6.5M+24.8%	-$8.6M
Capital Expenditures	N/A	N/A	$0	$0	N/A	N/A	$5K	$0
Free Cash Flow	N/A	N/A	-$4.1M+23.6%	-$5.4M	N/A	N/A	-$6.5M+24.7%	-$8.6M
Investing Cash Flow	N/A	N/A	$630K	$0-100.0%	$2.5M	$0+100.0%	-$5K	$0
Financing Cash Flow	$18.0M+5391.4%	$328K-90.6%	$3.5M-21.4%	$4.5M+31.9%	$3.4M+2761.7%	-$127K-102.1%	$6.0M-34.4%	$9.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PTNTD Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	97.8%+6.5pp	91.4%+6.2pp	85.2%	N/A	100.0%
Operating Margin	N/A	-501.0%+167.7pp	-668.8%+1822.9pp	-2491.6%	N/A	-20007.6%
Net Margin	N/A	-662.3%-167.0pp	-495.2%+1969.8pp	-2465.1%	N/A	-19006.9%
Return on Equity	N/A	N/A	N/A	-222.5%-154.8pp	-67.7%-39.7pp	-28.0%
Return on Assets	N/A	-276.8%-142.8pp	-134.0%-33.6pp	-100.4%-50.4pp	-49.9%-23.5pp	-26.4%
Current Ratio	0.36-0.6	1.01-0.1	1.08-1.0	2.13-4.1	6.27-15.0	21.28
Debt-to-Equity	-1.68+95.7	-97.35-87.4	-9.93-11.1	1.22+0.9	0.36+0.3	0.06
FCF Margin	N/A	-701.6%-89.6pp	-612.0%+1443.5pp	-2055.5%	N/A	34972.4%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-6315.8%-6368.4pp	52.7%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-6260.0%-6312.9pp	52.9%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-63.3%-1243.4pp	1180.0%	N/A	N/A	N/A	N/A	N/A	-534.3%
Return on Assets	-40.5%-94.8pp	54.3%	N/A	-129.0%-72.4pp	-56.7%+172.4pp	-229.1%	N/A	-74.0%
Current Ratio	2.76+1.7	1.02+0.7	0.36+0.0	0.32-0.1	0.38+0.1	0.26-0.7	1.01-0.2	1.20
Debt-to-Equity	0.56-20.2	20.73+22.4	-1.68-0.1	-1.58+0.1	-1.68-0.2	-1.44+95.9	-97.35-103.6	6.22
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$4.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.36), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PTNTD's annual revenue?

PTNTD (PTNTD) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PTNTD's revenue growing?

PTNTD (PTNTD) revenue declined by 100% year-over-year, from $4.5M to $0 in fiscal year 2025.

What are PTNTD's total assets?

PTNTD (PTNTD) had $3.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are PTNTD's capital expenditures?

PTNTD (PTNTD) invested $0 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does PTNTD spend on research and development?

PTNTD (PTNTD) invested $14.9M in research and development during fiscal year 2025.

How many shares does PTNTD have outstanding?

PTNTD (PTNTD) had 929,597 shares outstanding as of fiscal year 2025.

What is PTNTD's current ratio?

PTNTD (PTNTD) had a current ratio of 0.36 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is PTNTD's debt-to-equity ratio?

PTNTD (PTNTD) had a debt-to-equity ratio of -1.68 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is PTNTD's debt-to-equity ratio negative or unusual?

PTNTD (PTNTD) has negative shareholder equity of -$4.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is PTNTD?

PTNTD (PTNTD) scores 13 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.